Introduction
The establishment of an appropriate uterine environment during mammalian embryogenesis depends upon complex interactions between embryo and uterus. An increasing body of evidence indicates that peptide-signalling molecules play an important role in this process. These include proteins originally identified as growth factors (see reviews by Hill et al, 1987 and Brigstock et al, 1989 ) and proteins such as cytokines that were identified in other cellular systems. These molecules are located in the uterus during pregnancy and have been shown to regulate the attachment, implantation, growth and develop¬ ment of embryo and fetus (Pollard et al, 1987; Wegmann, 1988; Arceci et al, 1989; Wegmann et al, 1989;  Pollard, 1990; Robertson et al, 1990) .
Myeloid leukaemia inhibitory factor (LIF) has pleiotropic activities in a number of mammalian cell systems (Hilton et al, 1988; Moreau et al, 1988; Smith et al, 1988; Williams et al, 1988; Gough et al, 1989; Metcalf 1989; Yamamori et al, 1989) .
Several lines of evidence indicate that this protein has impor¬ tant biological activities during early mammalian development (see review by Fry, 1992) . LIF is expressed at a variety of sites in both the mother and the early conceptus (Robertson et al, 1993) , and has potential biological effects on several cell types in the early embryo. In particular LIF is expressed by the maternal oviduct and uterus, and at high concentrations in the endometrial glands about the stage of implantation (Bhatt et al, 1991; Shen and Leder, 1992) . Embryonic LIF expression has been observed in the extraembryonic membranes of the egg cylinder embryo and continues after gastrulation (Conquet and Brûlet, 1990; Rathjen et al, 1990a) . In vitro, LIF can prevent the differentiation of embryonic stem cells (Smith et al, 1988; Williams et al, 1988) which are derived from, and closely related to, cells of the embryonic inner cell mass. Receptors for LIF have also been identified on trophectoderm cells (Fry, 1992) . Genetic experiments have indicated that overexpression of LIF in chimaeric embryos can inhibit gastrulation (Conquet et al 1992) , while mutation of the LIF gene in female mice prevents embryo implantation (Stewart et al, 1992 Lavranos and Seamark (1989) . Briefly, the num¬ bers of embryos achieving morula, blastocyst or hatching blastocyst stage as described by Hsu (1979) were recorded daily using an inverted microscope.
Embryo transfers
The procedure followed for embryo transfers was a modi¬ fication of the protocol described by Hogan et al (1986) (Hsu, 1979) and their rates of development following hCG treatment, were recorded. Further development of these embryos related to implantation was also monitored (Sherman, 1978 The procedure used for the preparation of mixed monolay¬ ers from whole uteri previously described by Salomon and Sherman (1975) (Lavranos and Seamark, 1989 (Rathjen et al, 1990b) (Rathjen et al, 1990b) . The reaction conditions were as described by Krieg and Melton (1987) with the exception that 250 pCi [a-32P]UTP (3000 Ci mmoN , 10 mCi ml-; Bresatec) was used in a 15 µ reaction volume. When using LIF clone pDR2 (Rathjen et al, 1990b) two RNAase protected fragments are produced. The larger fragment (368 nucleotides) corresponds to the diffusible form of LIF and the shorter fragment (345 nucleotides) to the matrix form of LIF, produced by the use of alternative exons at the 5' end (Rathjen et al, 1990b ). (Nomura el al, 1989) . Antisense RNA was generated using SP6 transcription of BamHI-linearized plasmid, and the three protected bands in mouse RNA represent heterogeneity at the 5' end as reported previously (Rathjen et al, 1990a (Fig. 1) . By day 7, the mean area of the inner cell mass of LIF-treated embryos (15.9 ± 10.6 µ 2) was significantly (P< 0.025) (Bhatt et al, 1991; Shen and Leder, 1992) (Fry, 1992) and on embryonic stem cells (Williams et al, 1988) (Heyner et al, 1989) (Rathjen et al, 1990a (Lavranos and Seamark, 1989 
